Huxtable CA, Roberts LJ, Somogyi AA, MacIntyre PE. Acute pain management in opioid-tolerant patients: a growing challenge. Anaesth Intensive Care 2011;39(5):804–23. https://www.ncbi.nlm.nih.gov/pubmed/21970125
Kirsh KL, Jass C, Bennett DS, Hagen JE, Passik SD. Initial development of a survey tool to detect issues of chemical coping in chronic pain patients. Palliat Support Care 2007;5(3):219–26. https://www.ncbi.nlm.nih.gov/pubmed/17969825
Lavand’homme P, Steyaert A. Opioid-free anesthesia opioid side effects: tolerance and hyperalgesia. Best Pract Res Clin Anaesthesiol 2017;31(4):487–98. https://www.ncbi.nlm.nih.gov/pubmed/29739537
Macintyre PE, Russell RA, Usher KA, Gaughwin M, Huxtable CA. Pain relief and opioid requirements in the first 24 hours after surgery in patients taking buprenorphine and methadone opioid substitution therapy. Anaesth Intensive Care 2013;41(2):222–30. https://www.ncbi.nlm.nih.gov/pubmed/23530789
Schug SA, Palmer GM, Scott DA, Halliwell R, Trinca J, APM:SE Working Group of the Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine, editors . Acute pain management: scientific evidence. 4th ed. Melbourne: Australian and New Zealand College of Anaesthetists and Faculty of Pain Medicine; 2015. https://pubmed.ncbi.nlm.nih.gov/27125806/
Stannard C, Gaskell H, Derry S, Aldington D, Cole P, Cooper TE, et al. Hydromorphone for neuropathic pain in adults. Cochrane Database Syst Rev 2016;(5):CD011604. https://www.ncbi.nlm.nih.gov/pubmed/27216018
Wiffen PJ, Derry S, Moore RA, Stannard C, Aldington D, Cole P, et al. Buprenorphine for neuropathic pain in adults. Cochrane Database Syst Rev 2015;(9):CD011603. https://www.ncbi.nlm.nih.gov/pubmed/26421677